Welcome to our dedicated page for Clover Health Investments news (Ticker: CLOV), a resource for investors and traders seeking the latest updates and insights on Clover Health Investments stock.
Clover Health Investments, Corp. (Nasdaq: CLOV) is a physician enablement technology company and Medicare Advantage insurer whose activities generate frequent news across healthcare, technology, and capital markets. The company focuses on Medicare Advantage PPO and HMO plans in several states and uses its Clover Assistant platform to support clinical decision-making and chronic disease management for people on Medicare.
News about Clover Health often centers on membership growth and plan performance in Medicare Advantage, including updates on enrollment during the Annual Enrollment Period, changes in plan offerings, and the design of affordable, high-choice PPO products. Company announcements also highlight clinical quality achievements, such as HEDIS performance and CMS Star Ratings for its PPO and HMO plans, which influence future payment years and are important to investors and healthcare partners.
Because Clover Health combines insurance operations with a technology platform, its news flow includes technology and data-driven care developments. This can involve new research and whitepapers from its subsidiary Counterpart Health on the impact of Counterpart Assistant, evidence on earlier diagnosis and reduced hospitalizations for chronic diseases, and platform enhancements such as ambient scribing, natural language chat, and enterprise-level tools for value-based care.
Investors and industry observers can also expect earnings releases, financial guidance updates, and SEC-related communications, including Form 8-K filings tied to quarterly results, responses to shareholder questions, and commentary on CMS rate and Star Rating changes. In addition, Clover Health periodically announces participation in major healthcare investor conferences and changes in its board of directors or governance structure.
This news page aggregates these developments in one place, allowing readers to follow Clover Health’s progress in Medicare Advantage, its technology initiatives through Clover Assistant and Counterpart Health, and its ongoing financial and regulatory disclosures over time.
Clover Health (Nasdaq: CLOV) will report its third quarter 2021 financial results on November 8, 2021, after market close. The company aims to improve health equity for underserved seniors in the U.S. A conference call will be held at 5:00 p.m. ET to discuss the financial results and business updates. Investors can access the call by dialing (833) 693-0547 for U.S. callers or (661) 407-1587 for international callers, using the conference ID 4264212. The event will also be available through a webcast on the company's investor relations website.
Summary not available.
Clover Health (Nasdaq: CLOV) has received an improved Medicare Star Rating of 3.5 stars for its PPO plans, reflecting enhanced access and quality of care for Medicare eligibles. Over 90% of Clover's Medicare Advantage members are enrolled in this PPO plan. The company's 2022 expansion will nearly double its reach to 209 counties across nine states. Notably, around 50% of Clover's members are people of color, surpassing the industry average. Clover aims to address systemic issues in healthcare accessibility, and the rating upgrade emphasizes their commitment to health equity.
Clover Health (Nasdaq: CLOV) introduces its 2022 Medicare Advantage plans aimed at providing affordable healthcare to underserved seniors across 209 counties in nine states, including Alabama, Arizona, and Texas. Enrollment begins on October 15 and extends until December 7, 2021, with coverage starting January 1, 2022. The plans offer low out-of-pocket costs, including $0 premiums and copays for primary care visits. Key benefits include over-the-counter allowances, dental, vision, and hearing coverage, affordable insulin prices, and access to telehealth and fitness classes, promoting comprehensive health support.
Clover Health (Nasdaq: CLOV) announced a significant expansion, gaining approval from the Centers for Medicare and Medicaid Services (CMS) to operate in 101 new counties starting January 1, 2022. This expansion nearly doubles their geographic footprint to 209 counties across nine states, including their new entry into Alabama. Eligible Medicare beneficiaries can enroll in Clover’s Medicare Advantage plans during the Annual Election Period from October 15 to December 7. This move aims to enhance access to affordable healthcare for underserved communities.
Clover Health has announced a partnership with MedArrive to provide in-home COVID-19 vaccinations for its medically complex and homebound members, starting in New Jersey. This initiative aims to address significant barriers to vaccination, particularly for seniors. The program is crucial as these populations face higher risks of serious illness from COVID-19. MedArrive's logistics platform will utilize healthcare professionals to improve patient outcomes and reduce hospital visits. Clover aims to enhance health equity and lower healthcare costs for its members by providing accessible, quality care.
Clover Health Investments, Corp. (Nasdaq: CLOV) has completed the redemption of all outstanding Public and Private Warrants as part of its IPO processes. As of September 13, 2021, approximately 97% of Public Warrants were exercised, resulting in 6,651,933 shares of Common Stock issued. The redemption generated cash proceeds of $385,653, and all Warrants have been delisted from trading. The company continues to trade its Class A Common Stock on the Nasdaq under the symbol CLOV, with no Warrants remaining outstanding.
Clover Health has partnered with athenahealth to provide clinical decision support via the Clover Assistant application. This integration allows Clover-contracted physicians to access personalized, data-driven insights while using their existing electronic health record (EHR) systems. The collaboration aims to reduce unnecessary documentation, enabling providers to focus more on patient care. Clover Health continues to prioritize improving health outcomes for seniors across multiple states in the U.S. with their Medicare Advantage plans.
Clover Health (CLOV) has partnered with Thyme Care to enhance oncology care for underserved seniors in New Jersey. This collaboration aims to bridge the gaps in cancer treatment by providing Clover's Medicare Advantage members with personalized support and resources at no cost. Thyme Care's technology will help identify at-risk members and deliver a dedicated care team, which includes physician-guided oncology nurses. Both companies share the mission of improving health equity and patient outcomes while reducing costs associated with cancer care.
Clover Health Investments, Corp. (Nasdaq: CLOV) announced that CEO Vivek Garipalli and President & CTO Andrew Toy will present at the 2021 Wells Fargo Virtual Healthcare Conference on September 9, 2021, at 3:20 p.m. Eastern Time. This presentation aims to highlight Clover Health's commitment to improving health equity for underserved seniors. A live webcast will be available on Clover Health's investor relations website, with an archived replay accessible for 12 months following the event.
For more information, visit Clover Health's investor relations page.